Retatrutide is an innovative research peptide investigated as a triple receptor agonist targeting the GLP-1, GIP and glucagon receptors. It is used in preclinical and experimental studies on metabolism, endocrinology and peptide research.
For research purposes only. This product is intended exclusively for laboratory and scientific research applications. Not suitable for use in humans or animals. Not intended for the diagnosis, treatment, cure, or prevention of any disease.
